123dartist / shutterstock.com
Teva and South Korean biopharmaceutical company Celltrion have entered into an exclusive partnership to commercialise two of Celltrion’s biosimilars in the US and Canada.
If you have already subscribed please login.
If you have any technical issues please email tech support.
Teva, Celltrion, biosimilar, EMA, partnership